Abstract
The use of 3,4-methylenedioxymethamphetamine (MDMA) has frequently been associated with increased levels of impulsivity during abstinence. The effects of MDMA on measures of impulsivity, however, have not yet been studied during intoxication. The present study was designed to assess the acute effects of MDMA and alcohol, alone and in combination, on behavioral measures of impulsivity and risk-taking behavior. A total of 18 recreational users of MDMA entered a double-blind placebo-controlled six-way crossover study. The treatments consisted of MDMA 0, 75, and 100 mg with and without alcohol. Alcohol dosing was designed to achieve a peak blood alcohol concentration (BAC) of about 0.06 g/dl during laboratory testing. Laboratory tests of impulsivity were conducted between 1.5 and 2 h post-MDMA and included a stop-signal task, a go/no-go task, and the Iowa gambling task. MDMA decreased stop reaction time in the stop-signal task indicating increased impulse control. Alcohol increased the proportion of commission errors in the stop-signal task and the go/no-go task. Signal detection analyses of alcohol-induced commission errors indicated that this effect may reflect impairment of perceptual or attentive processing rather than an increase of motor impulsivity per se. Performance in the Iowa gambling task was not affected by MDMA and alcohol, but there was a nonsignificant tendency towards improvement following alcohol intake. None of the behavioral measures of impulsivity showed a MDMA × alcohol interaction effect. The lack of interaction indicated that the CNS stimulant effects of MDMA were never sufficient to overcome alcohol-induced impairment of impulse control or risk-taking behavior.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Bechara A (2004). Separate neural substrates underlie different mechanisms of performance monitoring and behavioral control. In: Ullsperger M, Falkenstein M (eds). Errors, Conflicts and the Brain. Current Opinions on Performance Monitoring (MPI special issue in human cognitive and brain sciences). Max Planck-Institut fur Kognitions und Neurowissenschaften: Leipzig. pp 55–62.
Bechara A, Damasio H, Damasio AR (2000). Emotion, decision making and the orbitofrontal cortex. Cereb Cortex 10: 295–307.
Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE (2001). Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 39: 376–389.
Bolla KI, McCann UD, Ricaurte GA (1998). Memory impairment in abstinent MDMA (‘Ecstasy’) users. Neurology 51: 1532–1537.
Butler GK, Montgomery AM (2004). Impulsivity, risk taking and recreational ‘ecstasy’ (MDMA) use. Drug Alcohol Depend 76: 55–62.
Cole JC, Sumnall HR (2003). Altered states: the clinical effects of Ecstasy. Pharmacol Ther 98: 35–58.
de Wit H, Crean J, Richards JB (2000). Effects of D-amphetamine and ethanol on a measure of behavioral inhibition in humans. Behav Neurosci 114: 830–837.
de Wit H, Enggasser JL, Richards JB (2002). Acute administration of D-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 27: 813–825.
Fillmore MT, Kelly TH, Martin CA (2005). Effects of D-amphetamine in human models of information processing and inhibitory control. Drug Alcohol Depend 77: 151–159.
Fillmore MT, Rush CR, Hays L (2002). Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend 67: 157–167.
Fillmore MT, Rush CR, Marczinski CA (2003). Effects of D-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies. Drug Alcohol Depend 71: 143–152.
Fillmore MT, Vogel-Sprott M (1997). Resistance to cognitive impairment under alcohol: the role of environmental consequences. Exp Clin Psychopharmacol 5: 251–255.
Fillmore MT, Vogel-Sprott M (1999). An alcohol model of impaired inhibitory control and its treatment in humans. Exp Clin Psychopharmacol 7: 49–55.
Gamella JF, Alvarez-Roldan A, Romo N (1997). The content of ecstasy in Spain. In: Korf DJ RH (ed). Proceedings of the 7th Annual Conference on Drug Use and Drug Policy. Siswo: Amsterdam.
Gerra G, Zaimovic A, Giucastro G, Maestri D, Monica C, Sartori R et al (1998). Serotonergic function after (+/−)3,4-methylene-dioxymethamphetamine (‘Ecstasy’) in humans. Int Clin Psychopharmacol 13: 1–9.
Green AR, O'Shea E, Colado MI (2004). A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur J Pharmacol 500: 3–13.
Green DM, Swets JA (1966). Signal Detection Theory and Psychophysics. Wiley: New York.
Hernandez-Lopez C, Farre M, Roset PN, Menoyo E, Pizarro N, Ortuno J et al (2002). 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J Pharmacol Exp Ther 300: 236–244.
Jentsch JD, Taylor JR (1999). Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berlin) 146: 373–390.
Lamers CT, Ramaekers JG, Muntjewerff ND, Sikkema KL, Samyn N, Read NL et al (2003). Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance. J Psychopharmacol 17: 379–387.
Linnoila M, Virkkunen M, George T, Higley D (1993). Impulse control disorders. Int Clin Psychopharmacol 8 (Suppl 1): 53–56.
Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK (1983). Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 33: 2609–2614.
Logan BK, Couper FJ (2001). 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment. J Forensic Sci 46: 1426–1433.
Logan GD (1994). On the ability to inhibit though and action: a users’ guide to the stop signal paradigm. In: Dagenbach D, Carr TH (eds). Inhibitory processes in attention, memory and language. Academic Press: San Diego. pp 189–239.
Logan GD, Cowan WB, Davis KA (1984). On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 10: 276–291.
McCann UD, Eligulashvili V, Mertl M, Murphy DL, Ricaurte GA (1999). Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users. Psychopharmacology (Berlin) 147: 56–65.
McCann UD, Ridenour A, Shaham Y, Ricaurte GA (1994). Serotonin neurotoxicity after (+/−)3,4-methylenedioxymethamphetamine (MDMA; ‘Ecstasy’): a controlled study in humans. Neuropsychopharmacology 10: 129–138.
Moeller FG, Dougherty DM, Steinberg JL, Swann AC, Silverman PB, Kramer LA et al (2002). Heavy ‘ecstasy’ use is associated with increased impulsivity. Addict Disord Treatment 1: 47–52.
Monterosso J, Ehrman R, Napier KL, O'Brien CP, Childress AR (2001). Three decision-making tasks in cocaine-dependent patients: do they measure the same construct? Addiction 96: 1825–1838.
Morgan MJ (1998). Recreational use of ‘ecstasy’ (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19: 252–264.
Morgan MJ (2000). Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology (Berlin) 152: 230–248.
Mulvihill LE, Skilling TA, Vogel-Sprott M (1997). Alcohol and the ability to inhibit behavior in men and women. J Stud Alcohol 58: 600–605.
Nash JF (1990). Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis. Life Sci 47: 2401–2408.
Ortner CN, MacDonald TK, Olmstead MC (2003). Alcohol intoxication reduces impulsivity in the delay-discounting paradigm. Alcohol Alcohol 38: 151–156.
Parrott AC (2000). Human research on MDMA (3,4-methylene-dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change. Neuropsychobiology 42: 17–24.
Peroutka SJ, Pascoe N, Faull KF (1987). Monoamine metabolites in the cerebrospinal fluid of recreational users of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’). Res Commun Subst Abuse 8: 125–138.
Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff FA et al (2002). The acute and chronic effects of MDMA (‘ecstasy’) on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology 26: 387–396.
Ricaurte GA, Finnegan KT, Irwin I, Langston JW (1990). Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations. Ann NY Acad Sci 600: 699–708; discussion 708–710.
Richards JB, Zhang L, Mitchell SH, de Wit H (1999). Delay or probability discounting in a model of impulsive behavior: effect of alcohol. J Exp Anal Behav 71: 121–143.
Ridderinkhof KR, van den Wildenberg WP, Segalowitz SJ, Carter CS (2004). Neurocognitive mechanisms of cognitive control: the role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning. Brain Cogn 56: 129–140.
Steele TD, McCann UD, Ricaurte GA (1994). 3,4-Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): pharmacology and toxicology in animals and humans. Addiction 89: 539–551.
Steele TD, Nichols DE, Yim GK (1987). Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain. Biochem Pharmacol 36: 2297–2303.
Swann AC, Bjork JM, Moeller FG, Dougherty DM (2002). Two models of impulsivity: relationship to personality traits and psychopathology. Biol Psychiatry 51: 988–994.
Topp L, Hando J, Dillon P, Roche A, Solowij N (1999). Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend 55: 105–115.
Verkes RJ, Gijsman HJ, Pieters MS, Schoemaker RC, de Visser S, Kuijpers M et al (2001). Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology (Berlin) 153: 196–202.
Volkow ND, Wang GJ, Fowler JS (1997a). Imaging studies of cocaine in the human brain and studies of the cocaine addict. Ann NY Acad Sci 820: 41–54; discussion 54–55.
Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R et al (1997b). Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386: 830–833.
Acknowledgements
This work was conducted as part of the IMMORTAL research consortium funded by EU Grant GMA1-2000-27043.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramaekers, J., Kuypers, K. Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) on Behavioral Measures of Impulsivity: Alone and in Combination with Alcohol. Neuropsychopharmacol 31, 1048–1055 (2006). https://doi.org/10.1038/sj.npp.1300894
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1300894
Keywords
This article is cited by
-
MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity
Forensic Toxicology (2019)
-
Individual differences in voluntary alcohol intake in rats: relationship with impulsivity, decision making and Pavlovian conditioned approach
Psychopharmacology (2017)
-
Geweld door alcohol en drugs (II)
Verslaving (2017)
-
Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes
Brain Imaging and Behavior (2016)
-
Low-Dose Alcohol Effects on Measures of Inhibitory Control, Delay Discounting, and Risk-Taking
Current Addiction Reports (2016)
